Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Erleada“
Suchtreffer
Begriffe & Kennungen
Erleada · 4.5 · The effects of CYP3A4 or CYP2C8 inducers on the pharmacokinetics of apalutamide have not been evaluated in viv
Eintrag öffnenErleada · 4.5 · The elimination of apalutamide and formation of its active metabolite, N-desmethyl apalutamide, is mediated by
Eintrag öffnenErleada · 4.5 · The elimination of apalutamide and formation of its active metabolite, N-desmethyl apalutamide, is mediated by
Eintrag öffnenErleada · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenErleada · 4.6 Fertility, pregnancy and lactation · 2
Eintrag öffnenErleada · 4.8 Undesirable effects · 1
Eintrag öffnenErleada · 4.8 Undesirable effects · 2
Eintrag öffnenErleada · 4.8 · 28 uncommon: lichenoid eruption not known: drug reaction with eosinophilia and systemic symptoms (DRESS)e, Ste
Eintrag öffnenErleada · 4.8 · 8 Table 1: Adverse reactions System Organ Class Adverse reaction and frequency Blood and lymphatic system diso
Eintrag öffnenErleada · 4.8 · 9 dermatitis, and rash vesicular. Adverse reactions of skin rash were reported for 26% of patients treated wit
Eintrag öffnenErleada · 4.8 · Adverse reactions observed during clinical studies and/or in post-marketing experience are listed below by fre
Eintrag öffnenErleada · 4.8 · Adverse reactions observed during clinical studies and/or in post-marketing experience are listed below by fre
Eintrag öffnenErleada · 4.8 · Description of selected adverse reactions
Eintrag öffnenErleada · 4.8 · Description of selected adverse reactions
Eintrag öffnenErleada · 4.8 · Falls and fractures
Eintrag öffnenErleada · 4.8 · Falls and fractures
Eintrag öffnenErleada · 4.8 · Hypothyroidism
Eintrag öffnenErleada · 4.8 · Hypothyroidism
Eintrag öffnenErleada · 4.8 · Hypothyroidism was reported for 8% of patients treated with apalutamide and 2% of patients treated with placeb
Eintrag öffnenErleada · 4.8 · Hypothyroidism was reported for 8% of patients treated with apalutamide and 2% of patients treated with placeb
Eintrag öffnen